Veterinary Medicines

ANALGIN BIOPHARM 50% solution for injection

Authorised
  • Metamizole sodium monohydrate
Download as PDF

Identifikacija zdravila

Ime zdravila:
АНАЛГИН БИОФАРМ 50% инжекционен разтвор
ANALGIN BIOPHARM 50% solution for injection
Učinkovina:
Ciljne živalske vrste:
Pot uporabe:
  • Intravenska uporaba
  • intramuskularna uporaba

Podatki o zdravilu

Učinkovina / Jakost:
  • Na voljo samo v English
    500.00
    milligram(s)
    /
    1.00
    millilitre(s)
Farmacevtska oblika:
  • Raztopina za injiciranje
Withdrawal period by route of administration:
  • Intravenous use
    • Horse
      • Meat and offal
        17
        day
    • govedo
      • Meat and offal
        28
        day
    • Pig
      • Meat and offal
        17
        day
    • Dog
  • Intramuscular use
    • Horse
      • Meat and offal
        17
        day
    • govedo
      • Meat and offal
        28
        day
    • Pig
      • Meat and offal
        17
        day
    • Dog
Anatomsko-terapevtsko-kemična veterinarska oznaka (ATCvet):
  • QN02BB02
Pravni status za dobavo / izdajo zdravila:
  • Zdravilo, ki se izdaja na veterinarski recept
Status dovoljenja:
  • Valid
Authorised in:
  • Bulgaria
Opis ovojnine:

Dodatne informacije

Entitlement type:
Pravna podlaga za izdajo dovoljenja za promet z zdravilom:
Imetnik dovoljenja za promet z zdravilom:
  • Biopharm-Engineering AD
Marketing authorisation date:
Proizvodna mesta, odgovorna za sproščanje serij:
  • Biopharm-Engineering AD
Pristojni organ:
  • Bulgarian Agency For Food Safety
Številka dovoljenja :
  • 0022-3064
Datum spremembe statusa dovoljenja:

Dokumenti

Povzetek glavnih značilnosti zdravila

Ta dokument ne obstaja v tem jeziku (slovenščina). Spodaj ga najdete v drugem jeziku.
Bulgarian (PDF)
Objavljeno na: 11/01/2022
Prenesi
How useful was this page?:
Average: 5 (1 vote)
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."